GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RAMM Pharma Corp (XCNQ:RAMM) » Definitions » DeferredTaxAndRevenue

RAMM Pharma (XCNQ:RAMM) DeferredTaxAndRevenue : C$0.00 Mil (As of Jan. 2025)


View and export this data going back to 2019. Start your Free Trial

What is RAMM Pharma DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

RAMM Pharma's current deferred tax and revenue for the quarter that ended in Jan. 2025 was C$0.00 Mil.

RAMM Pharma DeferredTaxAndRevenue Historical Data

The historical data trend for RAMM Pharma's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RAMM Pharma DeferredTaxAndRevenue Chart

RAMM Pharma Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
DeferredTaxAndRevenue
Get a 7-Day Free Trial - - - - -

RAMM Pharma Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

RAMM Pharma DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of RAMM Pharma's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


RAMM Pharma Business Description

Traded in Other Exchanges
N/A
Address
82 Richmond Street E, Toronto, ON, CAN, M5C 1P1
RAMM Pharma Corp is engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The group generates revenue from the sale of medical devices and consumables, the sale of pharmaceutical products, and sale of cosmetics. Geographically, it derives a majority of its revenue from Uruguay.
Executives
Jackie Peter Burnett 10% Security Holder, Director, Senior Officer
Armando Gabriel Blankleider Director

RAMM Pharma Headlines

No Headlines